Related Experiment Video
Updated: Jul 1, 2026

Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Bariatric surgery improves atherogenic LDL profile by triglyceride reduction
Sabina Zambon1, Giovanna Romanato2, Giovanni Sartore2
1Department of Medical and Surgical Sciences, University of Padova, via Giustiniani, 2, 35128, Padova, Italy. sabina.zambon@unipd.it.
Laparoscopic gastric banding improved LDL particle size in obese patients by reducing triglycerides, not by altering fatty acids. This suggests triglyceride reduction is key to improving LDL profile after weight loss surgery.
Area of Science:
- Metabolic Syndrome
- Cardiovascular Health
- Bariatric Surgery
Background:
- Small dense low-density lipoprotein (LDL) particles are linked to obesity and increased cardiovascular risk.
- Fatty acids influence LDL particle characteristics.
- Understanding LDL changes post-bariatric surgery is crucial for managing obesity-related comorbidities.
Purpose of the Study:
- To investigate the relationship between plasma phospholipid fatty acid composition and small dense LDL particles in morbidly obese patients.
- To assess changes in LDL particle characteristics after laparoscopic gastric banding (LAGB).
Main Methods:
- Quantified plasma lipids, lipoproteins, apoproteins, and phospholipid fatty acid composition before and 12 months after LAGB.
- Assessed changes in small dense LDL and LDL relative flotation in 15 morbidly obese patients.
- Correlated these changes with weight loss and dietary fatty acid intake.
Main Results:
- LAGB significantly reduced BMI, triglycerides, and apoprotein E, while increasing HDL cholesterol.
- Small dense LDL decreased, and LDL relative flotation increased post-surgery.
- These LDL modifications were associated with triglyceride reduction, not weight loss or fatty acid changes.
Conclusions:
- Weight loss via LAGB improves the atherogenic LDL profile in morbidly obese individuals.
- Triglyceride reduction is the primary driver of improved LDL physical properties after LAGB.
- Dietary fatty acid composition does not appear to be a significant determinant of LDL changes post-LAGB.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drug Dosing: Obese Patients

